Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Adenocarcinoma|DS Stage I Plasma Cell Myeloma|DS Stage II Plasma Cell Myeloma|Metastatic Malignant Neoplasm to the Bone|Pain|Musculoskeletal Complication|Urinary Complications
Interventions: DRUG: zoledronic acid
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)